ABSTRACT The effects of leukotriene C4 (LTC4) on activation of muscarinic acetylcholine receptor (mAChR)-stimulated, inwardly rectifying K + current (I~Achl) were examined in single bullfrog atrial myocytes using the whole-cell patch clamp technique. LTC4 produced a reversible, concentration-dependent increase in steady-state, guanosine--y-thiotriphosphate (GTP~tS)-activated IKt^Chl, with a K0.5 of 3.1 IzM. LTC4 also increased the rate of GTP~/S-mediated IKIAChl activation, both in the absence and presence of 1 nM ACh, with comparable K0.5 values of 4.7 izM under basal conditions and 4.9 IzM in the presence of 1 nM ACh. LTC4 did not alter the relative affinities of the G protein, Gk, for GTP~/S and GTP. We hypothesize that all of the effects of LTC4 on the kinetics of Gk-mediated IKtACh] activation are produced at a common site with a K0.5 of 3-5 I~M. The effects of LTC4 on IKtACh] activation are fully reversible in the presence of GTP,IS. Under physiological conditions (i.e., intracellular GTP), 10 izM LTC4 increased the ACh-activated peak Ir4AChl. Inhibitors of cellular LTC4 production, including 5,8,11,14-eicosatetraynoic acid, baicalein, cinnamyl-3,47dihydroxy-a-cyanocinnamate , and a-pentyl-4-(2-quinolinylmethoxy)-benzene methanol, greatly attenuated ACh-dependent IrqAChl activation, preventing activation of peak, and producing a lower steady-state IKIAChl (when compared with the control response in the same cell). Addition of exogenous LTC4 was able to overcome the effects of LTC4 synthesis inhibitors, restoring both the peak and steady-state Iv4AChl responses. Although the mechanism of LTC4-mediated modulation of IKtACnl activation is not known, our results suggest that endogenously produced lipoxygenase metabolites of arachidonic acid, specifically LTC4, are involved in the physiological process of I~lAChl activation.
INTRODUCTION
Acetylcholine (ACh) binding to atrial muscarinic receptors (mAChR) induces activation of an inwardly rectifying potassium current, IK [ACh] . A pertussis toxin-sensitive G protein, Gk, couples mAChR to the K[ACh] channel. A variety of arachidonic acid metabolites, including leukotrienes, induce IK[ACh] activity at the single channel level (Kim, Lewis, Graziadei, Neer, Bar-Sagi, and Clapham, 1989; Kurachi, Ito, Sugimoto, Shimizu, Miki, and Ui, 1989) . Receptor-mediated arachidonic acid liberation and subsequent metabolism via the 5-1ipoxygenase pathway has been implicated in the activation OflK[ACh] via both ~-adrenergic (Kurachi, Ito, Sugimoto, Shimizu, Miki, and Ui, 1991) and platelet activating factor receptors (Nakajima, Sugimoto, and Kurachi, 1991) in mammalian atrial myocytes. It has been suggested that mAChR-mediated release of arachidonic acid occurs via direct ~/subunit activation of phospholipase A2 (PLA2; Kim et al., 1989; Clapham, 1990) , although more recent experiments suggest that [3~/ subunits are able to activate the K[ACh] channel despite the presence of inhibitors of arachidonic acid release and/or metabolism (Ito, Tung, Sugimoto, Kobayashi, Takahashi, Katada, Ui, and Kurachi, 1992) .
Both lipoxygenase and cyclooxygenase metabolites of arachidonic acid modulate whole-cell IK[AChl (Scherer and Breitwieser, 1990) , with the most pronounced stimulatory effect produced by the leukotriene LTC4. LTC4 increases both the rate of guanosine-~/-thiotriphosphate (GTP~/S)-mediated activation of IK [ACh] and the GTP,/S-mediated rate of IKtACh] activation in the presence of low concentrations (1-10 nM) of ACh, suggesting that its effects are additive with those of muscarinic agonists. The magnitude of steady-state IK[AChl (60 S after ACh application, following densensitization of peak current) is slightly increased by 10 ~M LTC4 in the presence of nordihydroguaiaretic acid (NDGA, a 5-and 12-1ipoxygenase inhibitor)when Gk was persistently activated by GTP~/S (Scherer and Breitwieser, 1990) , suggesting the possibility that some of the effects of LTC4 can be localized to either GTP~/S-activated Gk, the muscarinic K ÷ channel itself, or their interaction (since mAChR was uncoupled from the pathway).
In this report, we explore more fully the role of LTC4 in IK[AChl activation, to determine whether the effects are relevant to the physiological mechanism of mAChR-mediated K[ACh] channel activation. We find that all of the LTC4-mediated effects are half-maximal at 3-5 ~M, and that both the rate of Gk activation and the magnitude of GTP~/S-activated steady-state IK [ACh] are enhanced by LTC4. Since blockers of LTC4 biosynthesis decrease the magnitude of ACh-stimulated IK[ACh], we suggest that the presence of LTC4 is required for maximal mAChR-mediated IK [ACh] activation.
METHODS

Cell Preparation
Dissociated atrial myocytes were obtained from the bullfrog Rana catesbeiana with a collagenase/ trypsin perfusion procedure as previously described (Scherer and Breitwieser, 1990) . The heart was removed, rinsed in HEPES-buffered Ringers solution, and perfused with Ca~+-free Ringers solution (mM): 88.4 NaCI, 2.5 KCt, 1.8 MgCI2, 23.8 NaHCO3, 0.6 NaH2PO4, 2.5 pyruvate, 1 mg/ml fatty acid-free bovine serum albumin, and MEM vitamins and essential amino acids (1 pMml, 100X stock; Sigma Chemical Co., St. Louis, MO), equilibrated with 5% CO2 at 28°C. The heart was then perfused for 60 rain with a recirculating dissociating solution (25 ml of Ca2+-free Ringers containing 5 mM creatine, 50 U/ml penicillin, 50 ~,g/ml streptomycin, 0.4 mg/ml trypsin (Boehringer Mannheim Corp., Indianapolis, IN), and 2.3-2.5 mg/ml collagenase B (Clostridium histolyticum; Boehringer Mannheim Corp.). Myocytes were released from the dissected atria by agitation and diluted twofold with Ca2+-free Ringers plus 0.9 mM CaCI2, 5 mM glucose, 1 ~l/ml MEM vitamins and essential amino acids, 50 U/ml penicillin, and 50 ~.g/ml streptomycin, and stored in suspension at room temperature until use (within 6-8 h).
Solutions
Bath solution (HEPES-buffered Ringers solution) contained (raM): 90 NaCI, 2.5 KCI, 5 MgCI~, 2.5 CaCI2, and 20 HEPES, pH 7.4. To block Ca ~+ and Na + currents, 500 p.M CdCI2 and 5 ~M tetrodotoxin were added, respectively. The intracellular solution contained (raM): 80 K + aspartate, 30 KC1, 1 EGTA, 0.05 Na2GTP, 5 MgATP, and 5 HEPES, pH 7.4. When present, GTP,/S (1 raM) was added as the Li salt. Stock solutions of 5,8,11,14-eicosatetraynoic acid (ETYA; Calbiochem-Novabiochem Corp., La Jolla, CA or Cayman Chemical Co., Inc., Ann Arbor, MI), 5,6,7-trihydroxyflavone (baicalein; BIOMOL Research Labs Inc., Plymouth Meeting, PA), cinnamyl-3,4-dihydroxy-a-cyanocinnamate (CDC; BIOMOL Research Labs Inc.), and ct-pentyl-4-(2-quinolinylmethoxy)-benzenemethanol 238; BIOMOL Research Labs Inc.) B4 (6,8,10,14-eicosatetraenoic acid, 5,12- 4,6,9-pentadecatetraenyl-e-cysteinyl] (Cayman Chemical Co., Inc.) in either ethanol or 50:50 PBS/ethanol were stored at -80°C. Ethanol concentrations in the final extraceUular solutions did not exceed 3%, and were without effect in control experiments.
-[R-[R*,S*-(E,E,Z,Z)]])
Electrophysiology
Whole-cell patch clamp (Hamill, Marty, Neher, Sakmann, and Sigworth, 1981) of atrial myocytes was performed, with minor modifications, as previously described (Scherer and Breitwieser, 1990) . Electrodes were fabricated of square bore glass (1.0 mm o.d.; Glass Co. of America, Millville, NJ) on a Flaming Brown micropipette puller (Sutter Instrument Co., Novato, CA) and were used without fire-polishing. Tip potentials were corrected, but junction potentials were not. Voltage clamp protocols were generated with a computer-driven arbitrary waveform generator (model 75; Wavetek, San Diego, CA), or with PClamp software (version 5.5.1; Axon Instruments, Inc., Foster City, CA). The protocol for monitoring /K[ACh] utilized sequential 250-ms voltage steps to -90, -125, and -5 mV from a holding potential of -85 mV (with return to the holding potential between steps). Steady-state current-voltage relationships were determined by assessing the average current at the end of 250-ms voltage steps to various potentials. Pulse protocols were applied to the cell continuously from the moment of patch rupture. A 5-mV hyperpolarizing pulse from the holding potential was included in all protocols to allow continuous monitoring of the pipette series resistance, which was not electronically compensated (this procedure provides a measure of the access of pipette solutions to the interior of the cell; Breitwieser and Szabo, 1988) . Currents were measured with a List EPC-7 patch clamp amplifier (List, Darmstadt-Eberstadt, Germany) and monitored with a model 310 oscilloscope (Nicolet Instrument Corp., Madison, WI). Signals were digitized with a PCM-1 instrumentation adaptor (Medical Systems Corp., Greenvale, NY) and stored on VCR tape. Rates of IK~ACh] activation were estimated by recording the analog signal on an Astromed recorder (model Z100; Astro-Med, Inc., West Warwick, RI) or by linear fits to digitized PClamp files. Data are reported as mean +_ SEM. Dose-response relationships to the equations noted in the text were fit by least-squares minimization using the Marquardt-Levenberg algorithm (NFIT; Island Products, Galveston, TX). All experiments were performed at room temperature (22-24°C).
RESULTS
Effect of LTC4 on GTPyS-activated Steady-State IKfAChl
A variety of arachidonic acid metabolites, including leukotrienes, modulate activation of the muscarinic K + current, IKIAChl, in atrial myocytes (Kim et al., 1989; Kurachi et al., 1989; Scherer and Breitwieser, 1990) . In particular, LTC4 (10 p.M in the presence of 10 p.M NDGA, a 5-and 12-1ipoxygenase inhibitor), produces a slight increase in steady-state, GTP~/S-activated IK{AChl (Scherer and Breitwieser, 1990) . Because the LTC4-mediated increase in steady-state GTP~/S-activated IK[AChl may result from a novel regulatory mechanism, we examined the properties of this effect of LTC4. Pipette solutions contained 1 mM GTP~/S. A brief pulse of 1 p.M ACh was used to activate peak IK [ACh] , which declined to steady-state IK[ACh] (IK[AChlss), and persisted despite removal of ACh from the bath solution, as is illustrated for the control experiment in Fig. 1 A. Illustrated in Fig. 1 , B and C, are the effects of bath application of 1 and 10 I~M LTC4, respectively, on GTP~S-activated IK[ACh]ss-LTC4 reversibly elicits additional current, which is not affected by 10 tLM atropine, but is blocked by 0.5 mM Ba 2+ (data not shown). The current-voltage relationship of the LTC4-elicited current is qualitatively similar to the steady-state current-voltage relationship of IK [ACh] in the same cell ( Fig. 1 D, relationships plotted for the cell illustrated in Fig. 1 C at the times denoted by the various symbols), suggesting that LTC4 increases IK[ACh] rather than activating a distinct K + current. This interpretation is further supported by the fact that LTC4 has been shown to activate K[ACh ] channels in cell-attached and excised patches (Kim et al., 1989; Kurachi et al., 1989; Clapham, 1990) .
The LTC4-mediated increase in IK[ACh]ss occurs rapidly, and upon removal of LTC4 the current rapidly returns to the control level of GTP~/S-mediated steady-state IK[ACh] (Fig. 1 , B and C). The reversibility of this effect suggests that LTC4 does not act via a G protein--coupled receptor (which would mediate a persistent increase in /K[ACh]ss under these experimental conditions). The increase in IKIAChl induced by LTC4 is saturable (Fig. 2) . The line through the data points represents the fit to a single site model, with a K0.5 of 3. ETYA, which inhibits both cyclooxygenases and lipoxygenases (Tobias and Hamilton, 1979; Bokoch and Reed, 1981) , has no effect on GTP~/S-activated IK[ACh]ss at concentrations as high as 10 IxM. Fig. 3 illustrates a typical experiment, in which IK[AChl was first persistently activated in the presence of GTP~/S, and then ETYA (10 p.M) was applied. The lack of ETYA effect on GTP~S-activated IK[AChlss suggests that cellular production of LTC4 does not contribute significantly to the maintenance of GTP~/S-activated IK [ACh] ss. This result is not specific to ETYA, since other inhibitors of LTC4 synthesis such as baicalein (a lipoxygenase and leukotriene biosynthesis inhibitor; Sekiya and Okuda, 1982; Kimura, Okuda, and Arichi, 1987) , and 
LTC4 Modulation of GTPyS-mediated Activation of IK[AChl
LTC4 (10 ~M) increases the rate of GTP~/S-mediated activation of IK[ACh~ in both the absence and presence of ACh (Scherer and Breitwieser, 1990) . To establish whether these effects are mediated by LTC4 at the same site that modulates IK[ACh]ss, we determined the concentration dependence of the LTC4-mediated increases in IK [ACh] activation rates. A dose response for LTC4 in the presence of 1 nM ACh was also determined, and is illustrated in Fig. 4 C. Experiments were as in Fig. 4A , except that the cell was exposed to a solution containing both the test concentration of LTC4 and 1 nM ACh. The rate of IK [ACh] activation in the absence of LTC4 under these conditions was 0.76 ± 0.03 rain-1 (n = 5), which is consistent with the enhanced rate of IK[AChl activation mediated by I nM ACh (Breitwieser and Szabo, 1988) . The data of Fig The GTP~/S-mediated rate of IK [ACh] activation is normalized to the steady-state IK[ACh3 obtained in each cell, which has been considered to reflect the rate of Gk activation (Breitwieser and Szabo, 1988) . The rates of GTP~/S-mediated IK[AChl activation in the presence of LTC4 were also determined in this manner (Fig. 4) . This is an overestimate of the effect of LTC4 on the rate of Gk activation, however, since LTC4 can increase the steady-state GTP~/S-activated [K[ACh] (Fig. 2) independent of an effect on Gk activation (i.e., when all of Gk has been persistently activated by GTP~S). The two effects of LTC4 (i.e., on Gk activation and on steady-state GTP~/S-activated [K[ACh]) can be separated, however, since (a) the effect of LTC4 on IK[ACh]ss can be independently determined (Fig. 2) ; (b) the effect of LTC4 on IKtACh]~ is rapidly reversible (Fig. 1, B and C) ; and finally, (c) I~[AChlss determined in the absence of exogenous LTC4 is not a function of continued, endogenous LTC4 production (Fig.  3) . Plotted as dashed lines in Fig. 4 , B and C, are the dose-response relationships obtained by normalizing to the LTC4-modulated IK[ACh]ss (calculated from the dose-response relationship in Fig. 2 ). Estimated in this manner, the LTC4-mediated increases in IK[AChJss and in Gk activation rate each account for ~ 50% of the effect of LTC4 on the rates of GTP~/S-mediated IK [ACh] activation.
Effects of LTC4 on Gk Activation Rates
Gk activation incorporates a number of kinetically distinct steps, including release of GDP, binding of GTP (or GTP~/S), dissociation into a guanine nucleotide triphosphate-bound ~Xk plus [3~/, and diffusion of activated subunits to the I~Ach] channel. Any or all of these steps may be modulated by LTC4. We had previously assumed that the limiting rate of IK [ACh] activation was due to the slow, basal rate of GDP release from the inactive heterotrimeric Gk (Breitwieser and Szabo, 1988) , but it is possible that this step is not rate limiting under all conditions. LTC4 might affect the rate of GTP~/S-mediated IK~ACh] activation not by modulating the rate of GDP release, but by altering the relative GTP',/S/GTP affinities of the nucleotide-free form of Gk, i.e., increasing the affinity of Gk for GTP~S relative to GTP. To assess this possibility, we determined the effect of 3 ~M LTC4 on the rates of IK~ACh] activation in the presence of various GTP~/S/GTP concentration ratios. The rates of activation in the presence of LTC4 were determined as illustrated in Fig. 4 A, normalized to IK~ACh1~ measured in the absence of LTC4. The GTP~/S/GTP dose-response relationships are illustrated in Fig. 5 . The GTP~/S/GTP ratio that mediates the half-maximal IK~ACh] activation rate is 1.5 in both the presence and absence of 3 ~M LTC4, suggesting that LTC4 does not alter the relative affinities of Gk for GTP and GTP~/S. Although it is possible that LTC4 may alter the diffusion of subunits to the channel, this possibility seems unlikely since lipid analogues such as LTB4 and LTD4 did not mimic the effect, although they might be expected to produce comparable changes in membrane fluidity. Thus the most likely steps for LTC4 modulation of Gk activation rates are (a) the rate of GDP release or (b) the rate of dissociation of Gk subunits, once guanine nucleotide triphosphate has bound. These two steps are not distinguishable under our experimental conditions, and we thus lump them together into the term "Gk activation," which is clearly modulated by LTC4.
LTC4 Modulation of GTP-mediated Activation of Ir4AChl
The results of the previous sections suggest that LTC4 both enhances the rate of Gk activation and increases GTP~/S-activated IKtACh]ss. It is likely, therefore, that GTP- dependent IKtACh] activation should likewise be enhanced. We examined both the effects of exogenously applied LTC4 and blockers of endogenous LTC4 production on the activation of IK [ACh] by ACh in the presence of intracellular GTP.
A double ACh application protocol was developed to allow each cell to serve as its own control, as illustrated in Fig. 6A . ACh (1 IxM) was applied for 2 rain, followed by a return to control Ringers solution for at least 4 rain. 1 vLM ACh was then applied a second time in the absence (Fig. 6 A ) or presence of various modulators (Fig. 6, B-F) .
In the control experiment (Fig. 6 A ) Since exogenously applied LTC4 enhances peak IKEAChl activated in the presence of ACh, we determined whether endogenous LTC4 production might be responsible for activation of peak IKEAChi under control conditions. The ability of ACh to elicit IKEACh] in the presence of 10 p-M ETYA (which blocks endogenous production of leukotrienes from free arachidonic acid) or 5 p-M L-655,238 (which prevents activation of 5-1ipoxygenase activating protein [Evans et al., 1991] (Fig. 4) nor L-655,238 (data not shown) blocks GTP~/S-activated IKIAChlss" Nonspecific perturbations of the myocyte membrane that affect the mAChRmediated signal transduction pathway can be ruled out by determining whether the effects of ETYA and/or L-655,238 are mitigated by exogenously applied LTC4. When the second application of ACh includes both ETYA and LTC4 (Fig. 6 D) or L-655,238 and LTC4 (Fig. 6 F) , the time course and magnitude OflKtACh] resembles the response in the presence of ACh plus LTC4 (Fig. 6 B ) , suggesting that the effects of ETYA and L-655,238 can be attributed to block of endogenous LTC4 production.
Other inhibitors of LTC4 synthesis, including CDC and baicalein, also block activation of peak IKIAChl in response to application of 1 p-M ACh by the double pulse protocol illustrated in Fig. 6 . All of these compounds inhibit activation of peak IKIAChl, with more variable effects on steady-state IKIACh] (60--90 S after peak), as illustrated in Table I . The commonality of the effects with a variety of LTC4 synthesis inhibitors strongly supports a role of endogenous arachidonic acid metabolites, specifically LTC4, in activation of peak IKtACh].
DISCUSSION
LTC4 Modulation of IK[AChI Activation
We have used a variety of experimental strategies to investigate the role of LTC4 in modulating activation of the muscarinic K + channel of bullfrog atrial myocytes. We find that LTC4 enhances GTP,/S-mediated IK [ACh] activation by increasing both the apparent rate of Gk activation (either GDP release from Gk or dissociation of the activated Gk complex into ct GTP and 13~ subunits) and the ability of activated G , GTP and/or 133' subunits) to activate the K[ACh I channel. LTC4 does not alter the k ~0L k relative affinities of Gk for GTP and GTP~/S. All of the effects of LTC4 on IK [ACh] activation are produced with a K0.5 of 3-5 ~M, and we hypothesize that they are (Peppelenbosch, Tertoolen, den Hertog, and de Laat, 1992) , although little is known about the signal transduction mechanism(s). Activation of cardiac LTC4 receptors causes changes in cardiac contractility under conditions in which conversion of LTC4 to LTD4(LTE4) is prevented and alterations in cell Ca 2+ or IP3 are not observed Chiono, Heller, Andazola, and Herman, 1991) . LTC4 binding is not affected by GTP (Hogaboom, Mong, Wu, and Crooke, 1983; Mong, Wu, Scott, Lewis, Clark, Weichman, Kinzig, Gleason, and Crooke, 1985; Cristol et al., 1989) , suggesting that the receptor does not belong to the G protein-coupled superfamily. Binding sites for LTC4 are widely distributed , although a biological activity associated with LTC4 binding is not always apparent. Careful analysis of LTC4 binding sites suggests that some apparent LTC4 "receptors" may represent cytoplasmic enzymes such as glutathione transferase (Sun, Chau, Spur, Corey, Lewis, and Austen, 1986; Sun, Chau, and Austen, 1987) . Recent characterizations of LTC4 receptors have used isolated membranes and parallel assays for enzymatic binding sites, as well as serine borate to prevent LTC4 metabolism to LTD4(LTE4) Chiono et al., 1991) . It remains clear that LTC4 receptors represent a distinct class with potentially novel signaling mechanisms.
Binding studies in membranes isolated from bullfrog ventricle (Chiono et al., 1991 ) indicated a single class of LTC4 binding sites with Kd of 34 nM and a Bmax of 52 pmol/mg protein (in the presence of 45 mM L-serine borate), with a decrease in affinity of two orders of magnitude in the absence of serine/borate. LTC4 binding was not antagonized by up to 10 p.M LTD4, 30 ~M LTE4, or GTP~S. Our data in bullfrog atrial myocytes are consistent with the characteristics of LTC4 receptors in membranes of bullfrog heart. LTC4-mediated modulation of IK[ACh] activation does not involve a G protein-mediated pathway, since the LTC4 effect is rapidly reversible upon washout of the lipid, even in the presence of GTP'yS. Since our electrophysiological experiments were performed in the absence of serine borate, the Ko.5 for modulation is in line with that observed by Chiono et al. (1991) . In addition, neither LTB4 nor LTD 4 was able to mimic the effect of LTC4, suggesting that the responses are specifically initiated by activation of LTC4 receptors.
Mechanism of LTC4-mediated IK[ACh ] Modulation
The increasing complexity of the mechanism of IK[ACh] activation, via muscarinic (Breitwieser and Szabo, 1985; Pfaffinger, Martin, Hunter, Nathanson, and Hille, 1985) , cq-adrenergic (Kurachi et al., 1989; Braun, Fedida, and Giles, 1992) , adenosine (Kurachi, Nakajima, and Sugimoto, 1986) , platelet activating factor (Nakajima et al., 1991; Ramos-Franco, Lo, and Breitwieser, 1993) , and calcitonin gene-related peptide (Kim, 1991) receptors suggests that multiple signal transduction pathways (and distinct identities of coupling G proteins) are possible. In addition, both Otk and [3"y subunits may play multiple roles in IK [ACh] activation (Breitwieser, 1991) , including potential direct interaction with the KIACh I channel (Birnbaumer, Abramowitz, and Brown, 1990; Birnbaumer, 1992; Ito et al., 1992) , activation of phospholipases (Clapham, 1990) , and potential participation in desensitization via 13~/ binding to f3-adrenergic receptor kinase or the muscarinic receptor kinase homologue (Haga and Haga, 1992; Pitcher, Inglese, Higgins, Arriza, Casey, Kim, Benovic, Kwatra, Caron, and Lefkowitz, 1992) . A region of the ai subunit NH 2 terminus has been implicated in the interaction with 13~/, and may also be involved in modulation of the GDP release rate during G protein activation (Osawa, Khanasekaran, Woon, and Johnson, 1990; Dhanasekaran, Osawa, and Johnson, 1991) , and thus the stability of the interaction between ak and [3~ is also a potential site for modulation.
The results of our experiments suggest that some of the kinetic properties of the muscarinic receptor-Gk-K[Achl channel signal transduction pathway are altered by LTC4 to produce enhanced activation of the K[ACh ] channel. Furthermore, our results suggest that cellular biosynthesis of LTC4 may contribute to the process of IK [ACh] activation; i.e., LTC4 is required for the rapid, ACh-mediated activation of IK [ACh] under physiological (GTP) conditions, but is not required for maintenance of steady-state/K[ACh] in the presence of either GTP or GTP~/S. The mechanism(s) by which LTC4 mediates its effects on Gk activation cannot be resolved from the present experiments, but it is possible that either C~k or [3~ or their interaction with each other or the K[ACh ] channel may be altered by LTC4. We suggest that these latter participants in the signal transduction pathway are most likely to be affected, since the response to LTC4 can be observed in the absence of mAChR stimulation, or after all of Gk has been persistently activated by GTP~S. Since LTC4 receptors have not been well characterized (and no selective antagonists exist), we cannot distinguish between direct interaction of LTC4 with proteins in the K [ACh ] channel signal transduction pathway, or mediation of the effects by a potential LTC4 receptor and novel signal transduction mechanism. Further experiments are required to fully define the role(s) for arachidonic acid metabolites in the modulation oflK [ACh] activation, and the potential contributions of cellular lipid metabolism to regulation of other G protein-dependent processes.
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